Research Article

The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC

Table 6

Univariate analysis of factors associated with OS and PFS in ESCC patients.

CharacteristicOSPFS
95% CI value95% CI value

Age (years)
<60/≥6024.681-37.319 vs. 31.774-48.2265.3600.0213.920-34.080 vs. 14.944-45.0563.7610.05
Gender
Male/female30.714-26.587 vs. 26.587-45.4130.0810.7816.493-31.507 vs. 13.258-48.7421.0770.30
Ethnicity
Han/Kazakh25.206-46.794 vs. 33.988-46.0120.1640.6716.037-31.963 vs. 19.773-42.2271.1360.29
Tumor location
Upper/middle/lower20.088-75.912 vs. 34.733-45.267 vs. 25.607 vs. 40.3932.1830.340-99.530 vs. 11.042-40.958 vs. 10.175 vs. 37.8251.0630.59
Tumor size
<3 cm/≥3 cm35.063-48.937 vs. 24.025-41.9754.2670.0433.675-46.325 vs. 15.498-24.5023.9080.04
Degree of differentiation
Poor/moderate/well12.573-43.427 vs. 34.313-45.687 vs. 28.959-51.0416.5210.0415.678-20.322 vs. 15.539-32.641 vs. 20.402-99.5989.0720.01
Lymph node metastasis
Negative/positive33.142-48.858 vs. 15.820-24.1808.7300.00329.674-42.326 vs. 6.921-17.07911.8880.001
Invasive depth
Mucosa/muscularis/full thickness0-85.4 vs. 35.377-44.623 vs. 28.313-43.6870.4870.780-39.4 vs. 17.492-42.508 vs. 16.086-31.9142.1090.35
AJCC stage
I/II/III/IV6.073-65.927 vs. 33.591-48.409 vs. 17.713-22.287 vs. 5.721-54.2797.2610.060-46.624 vs. 28.118-43.882 vs. 12.85-21.15 vs. 8.911-15.0899.9110.02
Vascular invasion
Negative/positive30.609-41.391 vs. 31.516-48.4840.2740.6015.312-38.688 vs. 11.752-36.2480.6340.43
Nerve invasion
Negative/positive34.737-45.263 vs. 6.270-41.7305.1970.0219.232-40.768 vs. 0-32.4797.2720.007
Hematogenous metastasis
Negative/positive29.139-42.861 vs. 31.769-40.2310.5470.4619.595-40.405 vs. 3.368-36.6323.4070.07
MACC1 expression
Negative/positive27.368-38.632 vs. 25.557-58.4436.9850.00813.556-34.444 vs. 17.052-42.9481.9210.17
c-Met expression
Negative/positive29.822-43.453 vs. 49.128-65.14321.173<0.00112.271-23.729 vs. 28.620-47.7408.9910.003
Cyclin D1 expression
Negative/positive27.638-44.362 vs. 31.777-40.2230.1110.7421.643-48.357 vs. 18.494-29.5060.3020.58

Abbreviations: ESCC: esophageal squamous cell carcinoma; AJCC: American Joint Committee on Cancer; OS: overall survival; PFS: progression-free survival.